drugset / Trial / NCT04894266
An Open-Label Study of Apabetalone in Covid Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of the study is to evaluate the safety and effect on clinical course of oral apabetalone in hospitalized subjects with Covid-19 infection
Timeline
- Start
- 2022-01-14
- Primary completion
- 2022-06-22
- Completion
- 2022-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apabetalone | Small molecule | 100 mg | — |